Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
48
ALGN Quote, Financials, Valuation and Earnings
Last price:
$192.24
Seasonality move
:
1.03%
Day range:
$187.72 - $193.53
52-week range:
$141.74 - $263.24
Dividend yield:
0%
P/E ratio:
34.65x
P/S ratio:
3.56x
P/B ratio:
3.63x
Volume:
1.1M
Avg. volume:
845K
1-year change:
-23.15%
Market cap:
$13.8B
Revenue:
$4B
EPS (TTM):
$5.49
Analysts' Opinion
-
Consensus RatingAlign Technology has received a consensus rating of Buy. The company's average rating is a Buy based on 9 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $233.81, Align Technology has an estimated upside of 22.9% from its current price of $190.24.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $180.00 representing 5.38% downside risk from its current price of $190.24.
Fair Value
-
According to the consensus of 14 analysts, Align Technology has 22.9% upside to fair value with a price target of $233.81 per share.
ALGN vs. S&P 500
-
Over the past 5 trading days, Align Technology has underperformed the S&P 500 by -5.17% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Align Technology does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Align Technology revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Align Technology reported revenues of $979.3M.
Earnings Growth
-
Align Technology earnings have been falling on a year-over-year basis for 4 quarters in a row. In the most recent quarter Align Technology reported earnings per share of $1.27.
Enterprise value:
12.9B
EV / Invested capital:
--
Price / LTM sales:
3.56x
EV / EBIT:
19.78x
EV / Revenue:
3.24x
PEG ratio (5yr expected):
1.53x
EV / Free cash flow:
20.48x
Price / Operating cash flow:
22.48x
Enterprise value / EBITDA:
16.06x
Gross Profit (TTM):
$2.8B
Return On Assets:
6.61%
Net Income Margin (TTM):
10.29%
Return On Equity:
10.72%
Return On Invested Capital:
10.72%
Operating Margin:
13.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $3.7B | $3.9B | $4B | $997.4M | $979.3M | |
| Gross Profit | $2.6B | $2.7B | $2.8B | $697.8M | $680.1M | |
| Operating Income | $589.5M | $677.3M | $652.9M | $154.1M | $135.3M | |
| EBITDA | $721.5M | $816.8M | $804.1M | $187.1M | $174.4M | |
| Diluted EPS | $4.05 | $6.07 | $5.49 | $1.39 | $1.27 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $2.5B | $2.3B | $2.5B | $2.4B | |
| Total Assets | $5.1B | $5.9B | $5.9B | $6.2B | $6.1B | |
| Current Liabilities | $1.4B | $1.9B | $2B | $2B | $2B | |
| Total Liabilities | $1.7B | $2.3B | $2.4B | $2.4B | $2.3B | |
| Total Equity | $3.4B | $3.7B | $3.5B | $3.8B | $3.8B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $738.1M | $614.5M | $762.2M | $28.7M | $52.7M | |
| Cash From Investing | -$175.9M | -$222.7M | -$200.6M | -$79.6M | -$25.3M | |
| Cash From Financing | -$648.9M | -$351.1M | -$550.8M | -$11.7M | -$206.8M | |
| Free Cash Flow | $469.4M | $491.6M | $630.7M | $19.3M | $27.4M | |
ALGN
Sector
Market Cap
$13.8B
$34.4M
Price % of 52-Week High
72.27%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
4.56%
-1.01%
1-Year Price Total Return
-23.15%
-37.36%
Beta (5-Year)
1.633
0.614
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$197.36
200-day SMA
Sell
Level
$200.64
Bollinger Bands (100)
Buy
Level
165.93 - 190.25
Chaikin Money Flow
Buy
Level
217.7M
20-day SMA
Sell
Level
$191.33
Relative Strength Index (RSI14)
Sell
Level
49.55
ADX Line
Sell
Level
12.23
Williams %R
Neutral
Level
-67.8331
50-day SMA
Buy
Level
$185.10
MACD (12, 26)
Buy
Level
3.92
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
92M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.558)
Buy
CA Score
(Annual)
Level (0.7802)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-1.5626)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients’ teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Stock Forecast FAQ
In the current month, ALGN has received 9 Buy ratings 5 Hold ratings, and 0 Sell ratings. The ALGN average analyst price target in the past 3 months is $233.81.
-
Where Will Align Technology Stock Be In 1 Year?
According to analysts, the consensus estimate is that Align Technology share price will rise to $233.81 per share over the next 12 months.
-
What Do Analysts Say About Align Technology?
Analysts are divided on their view about Align Technology share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Align Technology is a Sell and believe this share price will drop from its current level to $180.00.
-
What Is Align Technology's Price Target?
The price target for Align Technology over the next 1-year time period is forecast to be $233.81 according to 14 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is ALGN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Align Technology is a Buy. 9 of 14 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ALGN?
You can purchase shares of Align Technology via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Align Technology shares.
-
What Is The Align Technology Share Price Today?
Align Technology was last trading at $192.24 per share. This represents the most recent stock quote for Align Technology. Yesterday, Align Technology closed at $190.24 per share.
-
How To Buy Align Technology Stock Online?
In order to purchase Align Technology stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
